Exact Mass: 269.1627

Exact Mass Matches: 269.1627

Found 48 metabolites which its exact mass value is equals to given mass value 269.1627, within given mass tolerance error 4.0E-5 dalton. Try search metabolite list with more accurate mass tolerance error 8.0E-6 dalton.

Hepta-2,4-dienoylcarnitine

3-(hepta-2,4-dienoyloxy)-4-(trimethylazaniumyl)butanoate

C14H23NO4 (269.1627)


Hepta-2,4-dienoylcarnitine is an acylcarnitine. More specifically, it is an hepta-2,4-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Hepta-2,4-dienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Hepta-2,4-dienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Hepta-2,5-dienoylcarnitine

3-(hepta-2,5-dienoyloxy)-4-(trimethylazaniumyl)butanoate

C14H23NO4 (269.1627)


Hepta-2,5-dienoylcarnitine is an acylcarnitine. More specifically, it is an hepta-2,5-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. hepta-2,5-dienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine hepta-2,5-dienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(3Z,5E)-Hepta-3,5-dienoylcarnitine

3-(hepta-3,5-dienoyloxy)-4-(trimethylazaniumyl)butanoate

C14H23NO4 (269.1627)


(3Z,5E)-hepta-3,5-dienoylcarnitine is an acylcarnitine. More specifically, it is an (3Z,5E)-hepta-3,5-dienoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (3Z,5E)-hepta-3,5-dienoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (3Z,5E)-hepta-3,5-dienoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Isoretrohoustine

Isoretrohoustine

C14H23NO4 (269.1627)


   

MEGxp0_001369

MEGxp0_001369

C14H23NO4 (269.1627)


   

N-(3-Oxodecanoyl)-DL-homoserine lactone

N-(3-Oxodecanoyl)-DL-homoserine lactone

C14H23NO4 (269.1627)


   

6-O-Ac,3-O-isobutyryl,picrate-8-Methyl-8-azabicyclo[3.2.1]octane-3,6-diol

6-O-Ac,3-O-isobutyryl,picrate-8-Methyl-8-azabicyclo[3.2.1]octane-3,6-diol

C14H23NO4 (269.1627)


   

3alpha-Acetoxy-6beta-isobutyryloxytropane

3alpha-Acetoxy-6beta-isobutyryloxytropane

C14H23NO4 (269.1627)


   

3-oxo-C10-homoserine lactone

3-oxo-C10-homoserine lactone

C14H23NO4 (269.1627)


CONFIDENCE standard compound; INTERNAL_ID 210

   

Tetranor-8-NO2-CLA

8-nitro-5E,7Z-tetradecadienoic acid

C14H23NO4 (269.1627)


   

Tetranor-5-NO2-CLA

5-nitro-5Z,7E-tetradecadienoic acid

C14H23NO4 (269.1627)


   

3O-C10-HSL

N-(3-oxo-decanoyl)-homoserine lactone

C14H23NO4 (269.1627)


   

Benzoic acid, 2-amino-5-(1-pyrrolidinyl)- (9CI)

Benzoic acid, 2-amino-5-(1-pyrrolidinyl)- (9CI)

C14H23NO4 (269.1627)


   

(2S)-5-Allyl-1,2-pyrrolidinedicarboxylic acid 1-(tert-butyl) 2-methyl ester

(2S)-5-Allyl-1,2-pyrrolidinedicarboxylic acid 1-(tert-butyl) 2-methyl ester

C14H23NO4 (269.1627)


   

tert-butyl 4-(3-oxobutanoyl)piperidine-1-carboxylate

tert-butyl 4-(3-oxobutanoyl)piperidine-1-carboxylate

C14H23NO4 (269.1627)


   

4-(2-Ethoxy-2-oxoethylidene)-1-piperidinecarboxylic acid tert-butyl ester

4-(2-Ethoxy-2-oxoethylidene)-1-piperidinecarboxylic acid tert-butyl ester

C14H23NO4 (269.1627)


   

3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-6-yl isobutyrate

3a,4,5,6,7,7a-hexahydro-4,7-methano-1H-inden-6-yl isobutyrate

C14H23NO4 (269.1627)


   

4-((tert-Butoxycarbonyl)amino)bicyclo[2.2.2]octane-1-carboxylic acid

4-((tert-Butoxycarbonyl)amino)bicyclo[2.2.2]octane-1-carboxylic acid

C14H23NO4 (269.1627)


   

4-Allyl-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-4-piperidinecarbox ylic acid

4-Allyl-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-4-piperidinecarbox ylic acid

C14H23NO4 (269.1627)


   

(1S,2S,4R)-7-TERT-BUTYL 2-ETHYL 7-AZABICYCLO[2.2.1]HEPTANE-2,7-DICARBOXYLATE

(1S,2S,4R)-7-TERT-BUTYL 2-ETHYL 7-AZABICYCLO[2.2.1]HEPTANE-2,7-DICARBOXYLATE

C14H23NO4 (269.1627)


   

4-AMINO-CHROMAN-6-CARBONITRILEHYDROCHLORIDE

4-AMINO-CHROMAN-6-CARBONITRILEHYDROCHLORIDE

C14H23NO4 (269.1627)


   

1-Boc-4-allyl-4-piperidinecarboxylic Acid

1-Boc-4-allyl-4-piperidinecarboxylic Acid

C14H23NO4 (269.1627)


   

2-Methyl-2-propanyl 3-methyl-1-oxo-2-oxa-7-azaspiro[4.5]decane-7- carboxylate

2-Methyl-2-propanyl 3-methyl-1-oxo-2-oxa-7-azaspiro[4.5]decane-7- carboxylate

C14H23NO4 (269.1627)


   
   

1-TERT-BUTYL 3-ETHYL 3,4-DIHYDRO-1H-AZEPINE-1,3(2H,7H)-DICARBOXYLATE

1-TERT-BUTYL 3-ETHYL 3,4-DIHYDRO-1H-AZEPINE-1,3(2H,7H)-DICARBOXYLATE

C14H23NO4 (269.1627)


   

(4R,6R)-tert-Butyl-6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate

(4R,6R)-tert-Butyl-6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate

C14H23NO4 (269.1627)


   

Methyl 2-(4-((tert-butoxycarbonyl)aMino)cyclohexylidene)acetate

Methyl 2-(4-((tert-butoxycarbonyl)aMino)cyclohexylidene)acetate

C14H23NO4 (269.1627)


   

7-[(tert-butoxy)carbonyl]-7-azaspiro[3.5]nonane-2-carboxylic acid

7-[(tert-butoxy)carbonyl]-7-azaspiro[3.5]nonane-2-carboxylic acid

C14H23NO4 (269.1627)


   

methyl 6-{[(tert-butoxy)carbonyl]amino}spiro[3.3]heptane-2-carboxylate

methyl 6-{[(tert-butoxy)carbonyl]amino}spiro[3.3]heptane-2-carboxylate

C14H23NO4 (269.1627)


   

3-Allyl-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-3-piperidinecarbox ylic acid

3-Allyl-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-3-piperidinecarbox ylic acid

C14H23NO4 (269.1627)


   

1-[(2-methylpropan-2-yl)oxycarbonyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid

1-[(2-methylpropan-2-yl)oxycarbonyl]-2,3,3a,4,5,6,7,7a-octahydroindole-2-carboxylic acid

C14H23NO4 (269.1627)


   

3-Oxo-N-[(3s)-2-Oxotetrahydrofuran-3-Yl]decanamide

3-Oxo-N-[(3s)-2-Oxotetrahydrofuran-3-Yl]decanamide

C14H23NO4 (269.1627)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

1-methoxy-N-[(2,3,4-trimethoxyphenyl)methyl]-2-propanamine

1-methoxy-N-[(2,3,4-trimethoxyphenyl)methyl]-2-propanamine

C14H23NO4 (269.1627)


   

3-oxo-N-(2-oxooxolan-3-yl)decanamide

3-oxo-N-(2-oxooxolan-3-yl)decanamide

C14H23NO4 (269.1627)


   

Hepta-2,4-dienoylcarnitine

Hepta-2,4-dienoylcarnitine

C14H23NO4 (269.1627)


   

Hepta-2,5-dienoylcarnitine

Hepta-2,5-dienoylcarnitine

C14H23NO4 (269.1627)


   

(3Z,5E)-Hepta-3,5-dienoylcarnitine

(3Z,5E)-Hepta-3,5-dienoylcarnitine

C14H23NO4 (269.1627)


   

4-[3-(Tetrahydro-2H-pyran-2-yloxy)propyl]-1-aza-3-oxabicyclo[3.3.0]octan-2-one

4-[3-(Tetrahydro-2H-pyran-2-yloxy)propyl]-1-aza-3-oxabicyclo[3.3.0]octan-2-one

C14H23NO4 (269.1627)


   

(1r,7ar)-7-(hydroxymethyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2s)-2-hydroxy-2,3-dimethylbutanoate

(1r,7ar)-7-(hydroxymethyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2s)-2-hydroxy-2,3-dimethylbutanoate

C14H23NO4 (269.1627)


   

(1r,7as)-7-(hydroxymethyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2s)-2-hydroxy-2,3-dimethylbutanoate

(1r,7as)-7-(hydroxymethyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl (2s)-2-hydroxy-2,3-dimethylbutanoate

C14H23NO4 (269.1627)


   

(7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl)methyl 2-hydroxy-2,3-dimethylbutanoate

(7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl)methyl 2-hydroxy-2,3-dimethylbutanoate

C14H23NO4 (269.1627)


   

3-oxo-n-[(3s)-2-oxooxolan-3-yl]decanimidic acid

3-oxo-n-[(3s)-2-oxooxolan-3-yl]decanimidic acid

C14H23NO4 (269.1627)


   

7-hydroxy-1-(5-hydroxyhex-1-en-1-yl)-8-methyl-hexahydro-[1,3]oxazolo[3,4-a]pyridin-3-one

7-hydroxy-1-(5-hydroxyhex-1-en-1-yl)-8-methyl-hexahydro-[1,3]oxazolo[3,4-a]pyridin-3-one

C14H23NO4 (269.1627)


   

7-(hydroxymethyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 2-hydroxy-2,3-dimethylbutanoate

7-(hydroxymethyl)-2,3,5,7a-tetrahydro-1h-pyrrolizin-1-yl 2-hydroxy-2,3-dimethylbutanoate

C14H23NO4 (269.1627)


   

3-oxo-n-(2-oxooxolan-3-yl)decanimidic acid

3-oxo-n-(2-oxooxolan-3-yl)decanimidic acid

C14H23NO4 (269.1627)


   

[(7s,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2-hydroxy-2,3-dimethylbutanoate

[(7s,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2-hydroxy-2,3-dimethylbutanoate

C14H23NO4 (269.1627)


   

(1s,7s,8r,8as)-7-hydroxy-1-[(1e)-5-hydroxyhex-1-en-1-yl]-8-methyl-hexahydro-[1,3]oxazolo[3,4-a]pyridin-3-one

(1s,7s,8r,8as)-7-hydroxy-1-[(1e)-5-hydroxyhex-1-en-1-yl]-8-methyl-hexahydro-[1,3]oxazolo[3,4-a]pyridin-3-one

C14H23NO4 (269.1627)


   

[(7r,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2-hydroxy-2,3-dimethylbutanoate

[(7r,7ar)-7-hydroxy-5,6,7,7a-tetrahydro-3h-pyrrolizin-1-yl]methyl (2s)-2-hydroxy-2,3-dimethylbutanoate

C14H23NO4 (269.1627)